NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Phantom Neuro

Phantom Neuro

Private
Austin, TexasHealthcare & Life Scienceshttps://phantomneuro.com/

Last Round

Grant

Sep 10, 2025

Total Funding Raised

$28.56M

Company Overview

Phantom Neuro is a neurotechnology company developing a minimally invasive neural interface that enables intuitive control of prosthetic limbs and robotic exoskeletons.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Industrial Robotics, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

robotic prostheticsneurotechnologybrain-computer interfaceBCIprosthetic controlimplantable sensormuscle-machine interfaceelectromyographybionicsEMGneural interfaceassistive technologymedical deviceexoskeletonhuman augmentation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Phantom Neuro Comps

Public and private peers based on sector, stage, and business model.

Phantom Neuro comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Phantom Neuro Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 10, 2025
Series AApr 15, 2025
SeedSep 12, 2022
SeedMar 25, 2022

Phantom Neuro Investors

Notable investors and investment history

Phantom Neuro investors
InvestorRounds
Risk and ReturnSeries A
Brown AdvisorySeries A
Time BioVenturesSeries A, Seed
Risk and ReturnSeries A
Capital FactorySeed
MainSheet VenturesSeries A
E1 VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 1, 2025

    Launched a registry connecting amputees with neurointerface trials.

  • Oct 8, 2025

    CEO Connor Glass to present at BioFuture(TM) 2025 conference.

Phantom Neuro Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Phantom Neuro Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Phantom Neuro's valuation, stock price, and market status.

Firmographic Details

HeadquartersAustin, Texas
Employee Range19
Year Founded2020
Last FundingSep 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.